Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors.
OBJECTIVE
To summarize data supporting the effects of antidiabetes agents on glucose control and cardiovascular risk factors in patients with type 2 diabetes.


METHODS
Studies reporting on the effects of antidiabetes agents on glycemic control, body weight, lipid levels, and blood pressure parameters are reviewed and summarized for the purpose of selecting optimal therapeutic regimens for patients with type 2 diabetes.


RESULTS
National guidelines recommend the aggressive management of cardiovascular risk factors in patients with type 2 diabetes, including weight loss and achieving lipid and blood pressure treatment goals. All antidiabetes pharmacotherapies lower glucose; however, effects on cardiovascular risk factors vary greatly among agents. While thiazolidinediones, sulfonylureas, and insulin are associated with weight gain, dipeptidyl peptidase-4 inhibitors are considered weight neutral and metformin can be weight neutral or associated with a small weight loss. Glucagon-like peptide-1 receptor agonists and amylinomimetics (e.g. pramlintide) result in weight loss. Additionally, metformin, thiazolidinediones, insulin, and glucagon-like peptide-1 receptor agonists have demonstrated beneficial effects on lipid and blood pressure parameters.


CONCLUSIONS
Management of the cardiovascular risk factors experienced by patients with type 2 diabetes requires a multidisciplinary approach with implementation of treatment strategies to achieve not only glycemic goals but to improve and/or correct the underlying cardiovascular risk factors.
Kurukulasuriya
L Romayne
LR
Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, D109 Diabetes Center, UMC, One Hospital Drive, Columbia, MO 65212, USA. kurukulasuriyar@health.missouri.edu
Sowers
James R
JR
D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012307:Risk Factors
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human
Diabetes Care. 2005 May;28(5):1083-91
15855571
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005061
17054235
Acta Diabetol. 2007 Dec;44(4):187-92
17726570
J Med Invest. 2006 Feb;53(1-2):87-94
16538000
Diabetes Obes Metab. 2008 Dec;10(12):1204-11
18476983
Circulation. 2002 Dec 17;106(25):3143-421
12485966
JAMA. 2003 Jul 23;290(4):486-94
12876091
Obes Res. 2001 Nov;9 Suppl 4:326S-334S
11707561
Lancet. 2009 Feb 7;373(9662):473-81
18819705
Diabetes Obes Metab. 2008 Sep;10(10):959-69
18201203
Intern Med. 2008;47(13):1181-8
18591838
Circulation. 2004 Jul 13;110(2):227-39
15249516
J Clin Pharm Ther. 2009 Feb;34(1):13-23
19125899
Diabetes Care. 2004 Nov;27(11):2628-35
15504997
Curr Pharm Des. 2009;15(27):3179-92
19754390
Curr Opin Cardiol. 2008 Jul;23(4):340-9
18520718
J Am Coll Cardiol. 2005 Jun 21;45(12):1925-31
15963388
Diabetes Care. 2009 Jan;32(1):193-203
18945920
Diabetes Technol Ther. 2008 Jun;10(3):206-12
18473695
JAMA. 2007 Jul 11;298(2):194-206
17622601
J Clin Pharmacol. 2000 Jan;40(1):49-57
10631622
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61
19118286
Diabetologia. 2006 Nov;49(11):2564-71
17001471
Evid Rep Technol Assess (Summ). 2005 Aug;(128):1-11
16194123
J Am Coll Cardiol. 2007 Jan 23;49(3):290-7
17239709
N Engl J Med. 2008 Jun 12;358(24):2633-5
18539919
Expert Rev Endocrinol Metab. 2009 Mar;4(2):119-129
30780853
Diabetes Care. 1993 Apr;16(4):621-9
8462390
Lancet. 1998 Sep 12;352(9131):837-53
9742976
Am J Cardiovasc Drugs. 2005;5(3):201-9
15901207
Diabetes Obes Metab. 2008 Nov;10(11):1039-46
18355332
Diabetes Technol Ther. 2010 Mar;12(3):233-40
20151774
Obes Res. 2004 Apr;12(4):661-8
15090634
Diabetes Care. 2006 Mar;29(3):554-9
16505505
Diabet Med. 2005 Aug;22(8):980-5
16026361
Clin Pharmacol Ther. 2005 Dec;78(6):675-88
16338283
Ann Intern Med. 2007 Apr 3;146(7):477-85
17404349
Diabetes Obes Metab. 2001 Aug;3 Suppl 1:S34-43
11685828
Diabetes Care. 2005 Feb;28(2):366-71
15677794
Ann Intern Med. 2009 Sep 15;151(6):394-403
19620144
Curr Diabetes Rev. 2008 Nov;4(4):340-56
18991602
Vasc Health Risk Manag. 2008;4(2):355-62
18561511
Curr Med Res Opin. 2008 Jan;24(1):275-86
18053320
Endocr Pract. 2008 Nov;14(8):993-9
19095598
Curr Diabetes Rev. 2007 May;3(2):127-40
18220664
Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):347-60
19520308
Curr Med Res Opin. 2009 Oct;25(10):2401-11
19650754
Circulation. 2004 Jul 13;110(2):214-9
15197140
Hypertens Res. 2007 May;30(5):387-94
17587750
Curr Med Res Opin. 2008 Feb;24(2):537-50
18194595
Diabetes Care. 2008 Aug;31(8):1686-96
18663233
Stroke. 2004 May;35(5):1073-8
15073402
Diabetes Care. 2009 Jan;32(1):84-90
18931095
Curr Med Res Opin. 2008 Oct;24(10):2943-52
18786299
J Am Coll Nutr. 2003 Oct;22(5):331-9
14559925
Diabetes Care. 2008 Aug;31(8):1582-4
18458146
Diabet Med. 2008 Sep;25(9):1129-31
19183322
Lancet. 2006 Nov 11;368(9548):1696-705
17098089
Diabetes Care. 2006 Dec;29(12):2632-7
17130196
Metabolism. 2009 Mar;58(3):373-8
19217454
Circulation. 2009 Jan 27;119(3):e21-181
19075105
Diabetes Care. 2009 Sep;32(9):1649-55
19478198
Diabetes Care. 2006 Sep;29(9):2137-9
16936168
Int J Clin Pract. 2007 May;61(5):737-47
17493087
Diabetes Metab. 2006 Sep;32(4):344-9
16977262
Diabetes Care. 2005 May;28(5):1092-100
15855572
Lancet. 2009 May 23;373(9677):1765-72
19465231
Diabet Med. 2006 Feb;23(2):134-40
16433710
Diabetes Res Clin Pract. 2007 Aug;77(2):180-7
17239474
J Investig Med. 2007 Mar;55(2):62-8
17362692
Diabetologia. 2009 Jan;52(1):65-73
18985314
Endocr Pract. 2007 May-Jun;13 Suppl 1:1-68
17613449
J Intern Med. 2004 Jul;256(1):1-14
15189360
Lancet. 2008 Oct 4;372(9645):1240-50
18782641
Diabetes Care. 2007 Mar;30(3):753-9
17327355
Lancet. 2009 Jul 4;374(9683):39-47
19515413
Am J Hypertens. 2004 Nov;17(11 Pt 2):2S-6S; quiz A2-4
15539107
Am J Cardiovasc Drugs. 2007;7(5):319-35
17953471
JAMA. 2009 Sep 16;302(11):1186-94
19755697
Circulation. 2007 Jan 2;115(1):114-26
17192512
BMJ. 2000 Aug 12;321(7258):405-12
10938048
Chem Biol Interact. 2008 Jun 17;173(3):159-65
18485337
Diabetologia. 2006 Aug;49(8):1761-9
16736131
Curr Pharm Des. 2009;15(5):529-36
19199979
Diabetes Care. 2009 Jul;32(7):1224-30
19289857
N Engl J Med. 2008 Oct 9;359(15):1577-89
18784090
Atheroscler Suppl. 2006 Apr;7(1):37-42
16516560
Curr Diab Rep. 2008 Apr;8(2):126-31
18445355
Diabetes Care. 2004 Jan;27(1):256-63
14693998
J Clin Pharmacol. 2008 May;48(5):592-8
18353996
Treat Endocrinol. 2005;4(5):311-7
16185099
J Intern Med. 2005 Jan;257(1):100-9
15606381
Endocr Pract. 2009 Sep-Oct;15(6):540-59
19858063
Diabetes Care. 1998 Jun;21(6):987-93
9614619